Raiffeisen Bank International AG Buys New Holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Raiffeisen Bank International AG purchased a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 120,000 shares of the company's stock, valued at approximately $4,630,000. Raiffeisen Bank International AG owned about 0.13% of Acadia Healthcare as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also bought and sold shares of the business. Wellington Management Group LLP boosted its stake in shares of Acadia Healthcare by 0.7% in the 4th quarter. Wellington Management Group LLP now owns 11,734,743 shares of the company's stock valued at $465,283,000 after purchasing an additional 76,490 shares in the last quarter. FMR LLC boosted its position in Acadia Healthcare by 257.9% in the fourth quarter. FMR LLC now owns 6,230,631 shares of the company's stock valued at $247,045,000 after buying an additional 4,489,681 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of Acadia Healthcare by 18.0% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,182,729 shares of the company's stock worth $126,189,000 after buying an additional 486,395 shares in the last quarter. JPMorgan Chase & Co. lifted its stake in shares of Acadia Healthcare by 17.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company's stock valued at $198,258,000 after acquiring an additional 454,044 shares during the last quarter. Finally, Madison Avenue Partners LP acquired a new stake in shares of Acadia Healthcare during the 4th quarter valued at $76,339,000.

Acadia Healthcare Trading Down 4.6%

Shares of NASDAQ:ACHC traded down $1.17 during midday trading on Wednesday, reaching $24.03. The company's stock had a trading volume of 390,816 shares, compared to its average volume of 1,706,435. Acadia Healthcare Company, Inc. has a fifty-two week low of $20.36 and a fifty-two week high of $82.41. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The firm has a 50 day moving average price of $26.06 and a two-hundred day moving average price of $35.30. The firm has a market capitalization of $2.21 billion, a price-to-earnings ratio of 7.92, a PEG ratio of 1.46 and a beta of 1.01.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its quarterly earnings results on Monday, May 12th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.35 by $0.05. The firm had revenue of $770.51 million for the quarter, compared to analyst estimates of $769.90 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The company's revenue was up .3% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.84 earnings per share. As a group, analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

Wall Street Analysts Forecast Growth

ACHC has been the topic of a number of recent research reports. KeyCorp cut their price target on Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a research note on Wednesday, May 14th. Barclays decreased their price target on shares of Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating for the company in a research report on Wednesday, May 14th. Bank of America reduced their price objective on shares of Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating on the stock in a research note on Friday, February 28th. Mizuho lowered their target price on Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating for the company in a research report on Wednesday, May 14th. Finally, Guggenheim assumed coverage on Acadia Healthcare in a research report on Wednesday, April 9th. They issued a "buy" rating and a $36.00 price target on the stock. One research analyst has rated the stock with a sell rating, three have given a hold rating and six have given a buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $47.94.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.